Arctigenin efficiently enhanced sedentary mice treadmill endurance

PLoS ONE

Volumn 6, Issue 8, 2011, Pages

  Tang, Xuan ^a   Zhuang, Jingjing ^b   Chen, Jing ^a   Yu, Liang ^a   Hu, Lihong ^a   Jiang, Hualiang ^a   Shen, Xu ^a,b  

^a SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

^b EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARCTIGENIN; ARCTIUM LAPPA EXTRACT; CALCINEURIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; PLANT EXTRACT; PROTEIN SERINE KINASE; PROTEIN SERINE THREONINE KINASE; THREONINE PROTEINASE; UNCLASSIFIED DRUG; FATTY ACID; FURAN DERIVATIVE; LIGNAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARCTIUM; ARTICLE; BIOGENESIS; CONTROLLED STUDY; DRUG MECHANISM; DRUG STRUCTURE; ENDURANCE TRAINING; ENZYME PHOSPHORYLATION; FATIGUE; FATTY ACID OXIDATION; GENE EXPRESSION; GLUCOSE TRANSPORT; GLYCOLYSIS; IMMOBILIZATION; IN VIVO STUDY; INSULIN SENSITIVITY; MALE; MEDICINAL PLANT; MOUSE; MUSCLE TISSUE; NONHUMAN; TREADMILL EXERCISE; ANIMAL; CELL LINE; DRUG EFFECT; EXERCISE TEST; GENE EXPRESSION REGULATION; HERBAL MEDICINE; METABOLISM; MITOCHONDRION; MUSCLE; PHOSPHORYLATION; SEDENTARY LIFESTYLE; SIGNAL TRANSDUCTION;

ARCTIUM LAPPA; ASTERACEAE; MUS;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; CELL LINE; EXERCISE TEST; FATTY ACIDS; FURANS; GENE EXPRESSION REGULATION; HERBAL MEDICINE; LIGNANS; MICE; MITOCHONDRIA; MUSCLES; PHOSPHORYLATION; SEDENTARY LIFESTYLE; SIGNAL TRANSDUCTION;

EID: 80052045406     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0024224     Document Type: Article

References (63)

1. Short KR, Vittone JL, Bigelow ML, Proctor DN, Rizza RA, et al. (2003) Impact of aerobic exercise training on age-related changes in insulin sensitivity and muscle oxidative capacity. Diabetes 52 (8): 1888-1896.
2. Lira VA, Benton CR, Yan Z, Bonen A, (2010) PGC-1α regulation by exercise training and its influences on muscle function and insulin sensitivity. American journal of physiology. Am J Physiol Endocrinol Metab 299 (2): E145-161.
3. Goodpaster BH, Katsiaras A, Kelley DE, (2003) Enhanced Fat Oxidation Through Physical Activity Is Associated With Improvements in Insulin Sensitivity in Obesity. Diabetes 52: 2191-2197.
4. Puska P, Benaziza H, Porter D, (2003) Physical activity. World Health Organization. http://www.who.int/dietphysicalactivity/media/en/gsfs_pa.pdf.
5. Hardie DG, Carling D, Carlson M, (1998) The AMP-activated/SNF1 protein kinase subfamily: metabolic sensors of the eukaryotic cell? Annu Rev Biochem 67: 821-55.
6. Jäger S, Handschin C, St-Pierre J, Spiegelman BM, (2007) AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1α. Proc Natl Acad Sci U S A 104 (29): 12017-12022.
7. Hardie DG, (2007) AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy. Nat Rev Mol Cell Biol 8 (10): 774-785.
8. Woods A, Johnstone SR, Dickerson K, Leiper FC, Fryer LGD, et al. (2003) LKB1 Is the Upstream Kinase in the AMP-Activated Protein Kinase Cascade. Curr Biol 13 (22): 2004-2008.
9. Hawley SA, Pan DA, Mustard KJ, Ross L, Bain J, et al. (2005) Calmodulin-dependent protein kinase kinase-β is an alternative upstream kinase for AMP-activated protein kinase. Cell Metab 2 (1): 9-19.
10. Hurley RL, Anderson KA, Franzone JM, Kemp BE, Means AR, et al. (2005) The Ca2+/calmodulin-dependent protein kinase kinases are AMP-activated protein kinase kinases. J Biol Chem 280 (32): 29060-29066.
11. Narkar VA, Downes M, Yu RT, Embler E, Wang YX, et al. (2008) AMPK and PPARδ agonists are exercise mimetics. Cell 134 (3): 405-415.
12. Pette D, Staron RS, (2000) Myosin isoforms, muscle fiber types, and transitions. Microsc Res Tech 50 (6): 500-509.
13. Suwa M, Egashira T, Nakano H, Sasaki H, Kumagai S, (2006) Metformin increases the PGC-1α protein and oxidative enzyme activities possibly via AMPK phosphorylation in skeletal muscle in vivo. J Appl Physiol 101 (6): 1685-1692.
14. Puigserver P, (2003) Peroxisome Proliferator-Activated Receptor-γ Coactivator 1α (PGC-1α): Transcriptional Coactivator and Metabolic Regulator. Endocr Rev 24 (1): 78-90.
15. Wareski P, Vaarmann A, Choubey V, Safiulina D, Liiv J, et al. (2009) PGC-1α and PGC-1β regulate mitochondrial density in neurons. J Biol Chem 284 (32): 21379-21385.
16. Leone TC, Lehman JJ, Finck BN, Schaeffer PJ, Wende AR, et al. (2005) PGC-1α deficiency causes multi-system energy metabolic derangements: muscle dysfunction, abnormal weight control and hepatic steatosis. PLoS Biol 3 (4): e101.
17. Lin J, Wu PH, Tarr PT, Lindenberg KS, St-Pierre J, et al. (2004) Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1α null mice. Cell 119 (1): 121-135.
18. Summermatter S, Baum Oliver, Santos Gesa, Hoppeler H, Handschin H, (2010) Peroxisome proliferator-activated receptor γ coactivator 1α (PGC-1α) promotes skeletal muscle lipid refueling in vivo by activating de novo lipogenesis and the pentose phosphate pathway. J Biol Chem 285: 32793-32800.
19. Nadeau KJ, Ehlers LB, Aquirre LE, et al. (2006) exercise training and calorie restriction increase SREBP-1 expression and intramuscular triglyceride in skeletal muscle. Am J Physiol Endocrinal Metab 291 (1): E90-8.
20. Ikeda S, Miyazaki H, Nakatani T, Kai T, et al. (2002) Up-regulation of SREBP-1c and lipogenic genes in skeletal muscle after exercise training. Biochem Biophys Res Commun 296 (2): 395-400.
21. Schmitt B, Flück M, Décombaz J, Kreis R, Boesch C, Wittwer M, et al. (2003) Transcriptional adaptations of lipid metabolism in tibialis anterior muscle of endurance-trained athletes. Physiol Genomics 15 (2): 148-57.
22. Lin J, Wu H, Tarr PT, Zhang CY, Wu Z, Boss O, Michael LF, Puigserver P, Isotani E, Olson EN, Lowell BB, Bassel-Duby R, Spiegelman BM, (2002) Transcriptional co-activator PGC-1α drives the formation of slow-twitch muscle fibres. Nature 418 (August): 797-801.
23. Kim JY, Hwang JH, Cha MR, Yoon MY, Son ES, Tomida A, et al. (2010) Arctigenin blocks the unfolded protein response and shows therapeutic antitumor activity. J Cell Physiol 224 (1): 33-40.
24. Awale S, Lu J, Kalauni SK, Kurashima Y, Tezuka Y, Kadota S, et al. (2006) Identification of arctigenin as an antitumor agent having the ability to eliminate the tolerance of cancer cells to nutrient starvation. Cancer Res 66 (3): 1751-1577.
25. Sun S, Wang X, Wang C, Nawaz A, Wei W, Li J, et al. (2010) Arctigenin suppresses unfolded protein response and sensitizes glucose deprivation-mediated cytotoxicity of cancer cells. Planta Med.
26. Lee JY, Kim CJ, (2010) Arctigenin, a phenylpropanoid dibenzylbutyrolactone lignan, inhibits type I-IV allergic inflammation and pro-inflammatory enzymes. Arch Pharm Res 33 (6): 947-957.
27. Baar K, Wende AR, Jones TE, Marison M, Nolte LA, Chen M, et al. (2002) Adaptations of skeletal muscle to exercise: rapid increase in the transcriptional coactivator PGC-1. FASEB J 16 (14): 1879-1886.
28. Irrcher I, Adhihetty PJ, Sheehan T, Joseph AM, Hood DA, (2003) PPARγ coactivator-1α expression during thyroid hormone- and contractile activity-induced mitochondrial adaptations. Am J Physiol Cell Physiol 284 (6): C1669-1677.
29. Pilegaard H, Saltin B, Neufer PD, (2003) Exercise induces transient transcriptional activation of the PGC-1α gene in human skeletal muscle. J Physiol 546 (3): 851-858.
30. Zong H, Ren JM, Young LH, Pypaert M, Mu J, Birnbaum MJ, et al. (2002) AMP kinase is required for mitochondrial biogenesis in skeletal muscle in response to chronic energy deprivation. Proc Natl Acad Sci U S A 99 (25): 15983-15987.
31. Yan Z, (2009) Exercise, PGC-1α, and metabolic adaptation in skeletal muscle. Appl Physiol Nutr Metab 34 (3): 424-427.
32. Summermatter S, Baum O, Santos G, Hoppeler H, Handschin C, (2010) Peroxisome proliferator-activated receptor {gamma} coactivator 1{alpha} (PGC-1{alpha}) promotes skeletal muscle lipid refueling in vivo by activating de-novo lipogenesis and the pentose phosphate pathway. J Biol Chem 285 (43): 32793-32800.
33. Liang H, Ward WF, (2006) PGC-1alpha: a key regulator of energy metabolism. Adv Physiol Educ 30 (4): 145-151.
34. Cannon B, Houstek J, Nedergaard J, (1989) Brown Adipose Tissue More Than an Effector of Thermogenesis. Ann N Y Acad Sci 29 (856): 171-187.
35. Norrbom J, Sundberg CJ, Ameln H, Kraus WE, Jansson E, et al. (2004) PGC-1alpha mRNA expression is influenced by metabolic perturbation in exercising human skeletal muscle. J Appl Physiol 96 (1): 189-194.
36. Gibala MJ, McGee SL, Garnham AP, Howlett KF, Snow RJ, et al. (2009) Brief intense interval exercise activates AMPK and p38 MAPK signaling and increases the expression of PGC-1alpha in human skeletal muscle. J Appl Physiol 106 (3): 929-934.
37. Akimoto T, Pohnert SC, Li P, Zhang M, Gumbs C, et al. (2005) Exercise stimulates Pgc-1alpha transcription in skeletal muscle through activation of the p38 MAPK pathway. J Biol Chem 280 (20): 19587-19593.
38. Palomer X, Alvarez-Guardia D, Rodríguez-Calvo R, Coll T, Laguna JC, et al. (2009) TNF-alpha reduces PGC-1alpha expression through NF-kappaB and p38 MAPK leading to increased glucose oxidation in a human cardiac cell model. Cardiovasc Res 81 (4): 703-712.
39. Huss JM, Torra P, Staels B, Gigue V, Kelly DP, (2004) Estrogen-Related Receptor α Directs Peroxisome Proliferator-Activated Receptor α Signaling in the Transcriptional Control of Energy Metabolism in Cardiac and Skeletal Muscle. Mol Cell Biol 24 (20): 9079-9091.
40. Uguccioni G, Hood DA, (2010) The importance of PGC-1α in contractile activity-induced mitochondrial adaptations. Am J Physiol Endocrinol Metab.
41. Carling D, Clarke PR, Zammit VA, Hardie DG, (1989) Purification and characterization of the AMP-activated protein kinase. Copurification of acetyl-CoA carboxylase kinase and 3-hydroxy-3-methylglutaryl-CoA reductase kinase activities. Eur J Biochem 186 (1-2): 129-136.
42. Davies SP, Carling D, Hardie DG, (1989) Tissue distribution of the AMP-activated protein kinase, and lack of activation by cyclic-AMP-dependent protein kinase, studied using a specific and sensitive peptide assay. Eur J Biochem 186 (1-2): 123-128.
43. Hardie DG, (2008) Role of AMP-activated protein kinase in the metabolic syndrome and in heart disease. FEBS Lett 582 (1): 81-89.
44. Liu Q, Zhang Y, Lin ZH, Shen H, Chen LL, et al. (2010) Danshen extract 15,16-dihydrotanshinone I functions as a potential modulator against metabolic syndrome through multi-target pathways. J Steroid Biochem Mol Biol 120 (4-5): 155-163.
45. Hirshman MF, Brandauer J, Fujii N, Witters LA, Goodyear LJ, (2007) Skeletal Muscle Adaptation to Exercise Training AMP-Activated Protein Kinase Mediates Muscle Fiber Type Shift. Diabetes 56 (8): 2062-2069.
46. Kleiner S, Nguyen-Tran V, Olivia B, Huang XM, Spiegelman B, Wu ZD, (2009) PPARδ agonism activates fatty acid oxidation via PGC-1α but does not increase mitochondrial gene expression and function. J Biol Chem 284 (28): 18624-18633.
47. Sigal RJ, Kenny GP, Wasserman DH, Castaneda-Sceppa C, White RD, (2006) Physical activity/exercise and type 2 diabetes: a consensus statement from the American Diabetes Association. Diabetes Care 29 (6): 1433-1438.
48. Kraus WE, Houmard JA, Duscha BD, Knetzger KJ, Wharton MB, McCartney JS, et al. (2002) Effects of the amount and intensity of exercise on plasma lipoproteins. N Engl J Med 347 (19): 1483-1492.
49. Pescatello LS, Franklin BA, Fagard R, Farquhar WB, Kelley GA, Ray CA, (2004) American College of Sports Medicine position stand. Exercise and Hypertension. Med Sci Sports Exerc 36 (3): 533-553.
50. Pedersen BK, Saltin B, (2006) Evidence for prescribing exercise as therapy in chronic disease. Scand J Med Sci Sports 16 (Suppl 1): 3-63.
51. Goodyear LJ, (2008) clinical implications of basic research The Exercise Pill - Too Good to Be True? N Engl J Med 359; 17: 1842-1844.
52. Hood DA, (2009) Mechanisms of exercise-induced mitochondrial biogenesis in skeletal muscle. Appl Physiol Nutr Metab 472: 465-472.
53. Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, Daussin F, et al. (2006) Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1α. Cell 127 (6): 1109-1122.
54. Um JH, Park SJ, Kang H, Yang S, Foretz M, et al. (2010) AMP-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol. Diabetes 59 (3): 551-553.
55. Liu Q, Chen L, Hu L, Guo Y, Shen X, (2010) Small molecules from natural sources, targeting signaling pathways in diabetes. Biochim Biophys Acta 1799 (10-12): 854-865.
56. The Committee of Chinese Pharmacopoeia (2005) The Pharmacopoeia of the People's Republic of China. 1: 48-49.
57. Hayashi K, Narutaki K, Nagaoka Y, Hayashi T, Uesato S, (2010) Therapeutic effect of arctiin and arctigenin in immunocompetent and immunocompromised mice infected with influenza A virus. Biol Pharm Bull 33 (7): 1199-1205.
58. Jang YP, Kim SR, Kim YC, (2001) Neuroprotective dibenzylbutyrolactone lignans of Torreya nucifera. Planta Med 67 (5): 470-472.
59. Jang YP, Kim SR, Choi YH, Kim J, Kim SG, et al. (2002) Arctigenin protects cultured cortical neurons from glutamate-induced neurodegeneration by binding to kainate receptor. J Neurosci Res 68 (2): 233-240.
60. Hurley RL, Barre LK, Wood SD, Anderson KA, Kemp BE, et al. (2006) Regulation of AMP-activated protein kinase by multisite phosphorylation in response to agents that elevate cellular cAMP. J Biol Chem 281 (48): 36662-36672.
61. Pulinikunnil T, He H, Kong D, Asakura K, Peroni OD, et al. (2011) Adrenergic regulation of AMP-activated protein kinase in brown adipose tissue in vivo. J Biol Chem 286 (11): 8798-8809.
62. Davis JM, Murphy EA, Carmichael MD, Davis B, (2009) Quercetin increases brain and muscle mitochondrial biogenesis and exercise tolerance. Am J Physiol Regul Integr Comp Physiol 296 (4): R1071-1077.
63. Charter NW, Kauffman L, Singh R, Eglen RM, (2006) A generic, homogenous method for mesasuring kinase and inhibitor activity via adenosine 5′-diphosphate accumulation. J Biomol Screen 11 (4): 390-399.